[b]I hate to advocate drugs, alcohol, violence, or insanity to anyone, but they've always worked for me.[/b]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Fentanyl is a synthetic opioid 25 to 50 times more powerful than heroin. It is fast becoming a problem in the US. Synthesized in China it comes into the US by way of Mexico.
Rather than prescription fentanyl being abused this is street fentanyl. Extremely dangerous. Those pharmaceuticals that sell naloxone (narcan) to counter fentanyl overdoses may do well as the popularity of fentanyl grows.
mts I agree. Things are coming together fairly nicely IMO.
Now we just wait.
Thanks Lasers, Think I understand it now.
So is Setnik now employed by Elite or just a paid consultant?
Already read Lasers post so still unsure if she is a consultant.
Funny that she would be the person presenting.
So what made her present for Elite?
If she still has Pfizer connections it would make one go hmmmmmmmm.
Elite will be submitting another NDA once Pfizer gets approval.
Nasrat had said that Elite was waiting on Pfizers approval.
Things that make you go Hmmmm.
SequestOx approval then possibly 2 more NDA submissions before the end of 2016 with one being Pfizer related.
Lasers and N2K... very nice posts.
Could be sooner than later.
Go to the FDA site and find out.
Thorfin I personally dont think a reverse split will be needed.
Whatever shall be shall be.
For me the organic way is better. Reverse splits can be tricky.
Manipulation happens either way.
Already calling for reverse split? Huh?
SequestOx not even out of the gate. Other generics revenues ramping up. Forgot about the oxycodone Epic now Pura Pharm is making that Elite is getting a 15% revenue cut from?
Revenues should be pretty good this quarter and will continue to grow.
Once SequestOx is approved then what? More NDAs to the FDA? On a multi billion dollar pipeline that the FDA advisory committee gives its ADT labeling blessing to?
And some want to try to scare shareholders into thinking there will be a reverse split?
I tell ya.... you just cant make this stuff up.
Hey Hondobud,,, just trying to figure out patterns for a possible breakout.
Is Elite that far under the radar of most investors that typical patterns not showing.... OR smart money is already in thus the
chart as it is.
If you see anything Hondobud I am all ears. Thanks.
Where is DDRante when you need him. LOL
Wedge continuation formation.
http://www.trending123.com/patterns/falling_wedge.html
[
Not a scam Tim. Elite is the real deal becoming more reality as time goes on.
Elite may just become the market buzz for prescription opioid ADFs. A long shot for a Wall Street Darling but Elites story is compelling and may be enough to do the trick.
Nasrat is surrounding himself with experienced people on the BoD.
This is not a company that looks to me like it is ready to be bought out any time soon. Looks they want to grow.
Pretty soon all will be revealed with approval.
June or July 14th. It is coming soon.
Sharpei question for you.
Are we looking at a wedge pattern here with Elite?
Forget the 50 day and 200 day MA.
Seems like Elite is repeating the same pattern prior to the jump in level.
TIA
So glad I keep buying accumulating and holding. Thanks for those shares Tim.
Quite a difference between ELTP and KMPH. FDA advisory committee
to meet in June.
So is it June or July 14th? Sooner or later?
ROTFLMMFAO!
Great price entry time for those wishing to buy Elite shares.
Thanks NASDAQ. That was Sharp. ei?
Young ELTPstein a MoNsTeR in the making IMO.
Sharpei whenever you can... no rush. YOU are the one and only ChartMan. Appreciate any color you can add to the Elite picture.
All da best
JJ
Sharpei you out there? Your insight?
Letting go of support now at $0.30 for Elite.
Like I stated $0.29-$0.30?
Golden cross coming. Not if...... when.
Mssr Caskey is no news? Okay. Whatever you say. LOL
Another BoD selection for Elites BoD quiver
Davis Caskey...... tell me Nasrat is not setting the table for future success.
While at ECR, Mr. Caskey was credited with the establishment of ECR’s sales and marketing structure, its product distribution format, and management of the firm’s internal organization. His responsibilities included the oversight of drug development and regulatory filings. A primary focus was to conceive and develop, with the assistance of key strategic partners, extended release formulations of products which enhance patient compliance and safety. Prior to ECR, Mr. Caskey was employed by A.H. Robins for 18 years. His experience brings critical insight into the marketing and distribution of pharmaceutical products in a rapid and ever changing competitive marketplace.
Impressive..... very impressive.
Two new board members within the past few weeks. Cannnot wait for dinner to be served. Main entre' SequestOx.
Buddy every time I read your posts and see the Gene Wilder picture
it is almost like Gene is saying " Come to poppa! $ELTP "
Young ELTPstein.
jtf3 what party? NFL draft party? If so wrong board.
Talking Elite Pharmaceuticals here.
N2K do you have any perspective on the questions below?
TIA
Would be interesting to see what kind of results could be demonstrated if more robust opioid ADFs were available in Canada
despite the cost.
Now are we are talking the hard turtle shell that can be compromised with coke and lemon juice or simply microwaved?
Or is Canada talking about any potential ADF.
And where does one draw the line on cost and potentially saving lives? I guess Canada may not be a prime target after all.
Or maybe the problem gets so bad they re-evaluate ADFs cost versus lives. Their "review of the latest scientific evidence"
may need another review.
So in the meantime Canadians can call it collateral damage.....
So what ADFS did the Canadians use to derive this conclusion of "scientific evidence"? Interesting.... wow. Glad I live in the U S A.
Thanks Ultimaro71.
To me its much to do about nothing because once approved the lid will be off Elites Pandora's box.
Regardless of what "they" say ELI-200 is coming and there is not one thing they can do to stop it.
All the spin this way and that will not do a lick of good to stop Elites ADFs.
May is here.
July 14th 2016.
Mazzeppa as per your post the other day I have an answer for you
on another. I think Elite will do fine. As I am not a paying customer the only resource I have is the other.
Any chartists out there? Thanks in advance.
No thoughts namtae. My brain is empty.
Lone synapse stopped working. Sorry. LOL
Okay... I will play along with your assumption that Elites ADF is not taken seriously... thus no mention in the article.
That being said only a little over two months until July 14th 2016. Once approved by the FDA will it then be fair to see how
Elites ADF is received?
Will it then be fair to let Nasrat Hakim tout the benefits of having such a drug formulation on the market?
Once Elites SequestOx ADF is approved the gloves will be off. I suspect to be cautious is the only reason Elite is not promoting their ADF now. If one looks at the current trending of what 99% of pharmaceutical companies do before approval of their drugs one will see that Elite is acting no differently then they do. Better to side on caution rather than go the other way.
Approval is a 90% chance as it now stands. Two more NDAs more than likely pending upon approval of SequestOx.
CC coming in mid June.
I can wait another 2 months.
Share price is doing exactly what it needs to do for the 50MDA and the 200MDA to cross. Look for price to dip to $0.29- $0.30 temporarily.
Currently the share price for the 200MDA standa at $0.30.
50MDA share price stands at $0.31.
A penny difference does not seem like much for the two to converge... but it is still quite a bit. Time is on Elite longs side.
Grab shares while you can. This is a gift to all Elite longs.
The push down before the ride up.
Once the 200MDA and 50MDA cross it is my opinion that share price will go up significantly. It could signal the beginning of a real run. The Golden Cross is coming.
Just my opinion.
Who sold off? I see green and the Friday closing price of $0.33.
More fiction.......
Notice the intraday drop and green close pattern.
Mazeppa as per your reply... 200DMA intersecting with 50DMA is a golden cross. You are correct. Steady accumulation and bolstered
support with narrowing trading range.
Currently strong support at $0.32 with secondary support at $0.30.
Resistance at $0.33. Range has narrowed with light volume traded.
Death cross? NOT! Golden cross coming for Elite IMO.
I don't know? Which is the lie? Someone trying to create doubt
and confusion or someone with actual experience in the field?
So the FDA says within 6 months? So be it. July 14th, 2016. which is 2 months within 6 months. LMMFAO~! Hot Hot Hot!
NEXT!
Twist my words anyway you wish.
No slips on my part. Normal priority review is 6 months or longer.
Can take up to 18 months or longer in some cases.
Elite ELI-200 is going to be approved up to 2 months sooner than what a normal priority review would take which is 6 months minimum. That would have taken ELI-200 out to September or October.
So you do not work in pharmaceuticals I take it? Figured that out already. Your welcome.......... next!